Seizure Prediction on Dataset II (Leave-One-Out Cross-Validation)
99.1SensitivityHCFT
Evaluation results
| Method | Links | ||||
|---|---|---|---|---|---|
| HCFTSOP=30, SPH=3, Excluded Patients=04, 12, 13, 242026.01 | 99.1 | 2.36 | — | 98.82 | |
| ASRU-RWSOP=30, SPH=5, Evaluation Protocol=LOOCV (subject-specific), Excluded Patients=12, 152026.01 | 98.96 | 4.8 | — | — | |
| NSFA-NetSOP=30, SPH=5, Excluded Patients=04, 12, 15, 192026.01 | 98.68 | 3.8 | 0.906 | — | |
| MTLGSOP=30, SPH=5, Excluded Patients=04, 12, 13, 242026.01 | 98.24 | 3.3 | — | — | |
| M-d-CEvaluation Protocol=LOOCV2026.01 | 97.8 | 5.9 | 0.935 | — | |
| MSANSOP=60, SPH=5, Excluded Patients=04, 12, 15, 192026.01 | 96.27 | 0 | 0.93 | — | |
| TTTSOP=30, SPH=3, Excluded Patients=12, 13, 152026.01 | 96.01 | 4.7 | — | — | |
| BSDCNNSOP=30 (PIL), SPH=5, Excluded Patients=01, 05, 08, 10, 14, 222026.01 | 94.69 | 9.5 | 0.97 | — | |
| B2-ViTSOP=30, SPH=5, Excluded Patients=04, 06, 07, 08, 11, 12, 15, 16, 17, 222026.01 | 93.3 | 5.7 | 0.923 | — | |
| STCNNEvaluation Protocol=All Patients2026.01 | 92.94 | 7.3 | 0.9596 | — | |
| DWTSOP=25, SPH=5, Excluded Patients=04, 10, 06, 19 (for test)2026.01 | 91.7 | 0 | — | — | |
| TGCNNSOP=30, SPH=5, Excluded Patients=04, 06, 07, 11, 12, 15, 222026.01 | 91.5 | 14.5 | 0.935 | — | |
| DRSN-GRUSOP=30, SPH=5, Evaluation Protocol=LOOCV, Excluded Patients=01, 02, 03, 162026.01 | 90.54 | 11 | 0.88 | — | |
| HviT-DULSOP=30, SPH=1, Excluded Patients=04, 06, 07, 12, 152026.01 | 87.9 | 5.6 | 0.937 | — | |
| MAAEEvaluation Protocol=LODO, Excluded Patients=01, 03, 05, 06, 08, 10, 13, 14, 18, 202026.01 | 82.2 | 13 | 0.94 | — | |
| MCNNEvaluation Protocol=All patients2026.01 | 82 | 5.8 | — | — | |
| CNNSOP=30, SPH=5, Excluded Patients=04, 06, 08, 11, 12, 15, 17, 222026.01 | 81.2 | 16 | — | — |